DiaMedica Therapeutics Inc.
DMAC
$8.51
$0.536.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.96% | 0.10% | 2.44% | -25.92% | -22.56% |
| Total Depreciation and Amortization | 500.00% | -72.73% | 0.00% | 10.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.97% | -2.40% | 125.18% | 26.94% | 53.15% |
| Change in Net Operating Assets | 346.39% | -549.37% | -106.71% | -25.27% | 252.35% |
| Cash from Operations | 13.79% | -6.28% | -11.11% | -43.94% | 1.08% |
| Capital Expenditure | -166.67% | 50.00% | -71.43% | 22.22% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -387.29% | 35.11% | 27.28% | 193.47% | -217.74% |
| Cash from Investing | -387.66% | 35.26% | 27.22% | 193.20% | -217.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -50.00% | 33.33% | 0.00% | 0.00% | -50.00% |
| Issuance of Common Stock | 19,526.99% | 73.40% | -23.58% | -2.38% | -98.93% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 19,485.71% | 76.92% | -24.17% | -2.44% | -98.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -151.51% | 448.62% | 60.69% | 88.83% | -182.98% |